These benefits, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the notion of targeting ACKR3 as a novel technique to modulate the opioid system, which could open new therapeutic avenues for opioid-related disorders. (2) The doctor has obtained a https://jenningsm258qol8.idblogmaker.com/profile